Family Med Medical News about antipsychotics • prescribing trends • general population

Become a Member Today!
Register

Most Viewed Abstracts

1. AHA Guidelines on Cardiac CT for Assessing Coronary Artery Disease

2. Omega-3 fatty acids for bipolar disorder

3. Is folic acid good for everyone

4. ACS Releases Guidelines for HPV Vaccination

5. Vitamin D - A review Free full text

Your Article Summary

See Latest Articles

(Click the title below to leave the MDLinx Network and go to the Journal's Website)

Ginkgo biloba: specificity of neuropsychological improvement - a selective review in search of differential effects
Human Psychopharmacology: Clinical and Experimental, 06/30/09

Verdoux H. et al -Considering the growing number of persons from the general population exposed to APs, population studies assessing the risk/benefit ratio of SGAP use in disorders other than psychosis are necessary, particularly in children and adolescents.

Methods

Retrieved original studies that explored AP prescribing trends in general population samples since 2000.
For each study, we extracted information on sampling method, period, assessment of AP use and corresponding estimates (incidence rates, prevalence rates, pharmacy sales, prescription data) and diagnostic assessment.

Results

Nearly all studies meeting the inclusion criteria (n = 17) showed an increase in AP prescriptions, mainly because of a dramatic rise in second-generation antipsychotics (SGAP) prescriptions.
APs are often prescribed for non-psychotic disorders in adults as well as in children and adolescents.

<< Previous
Exceptional Brain Aging in a Rural Population-Based Cohort

Next >>
Acute Lower Respiratory Tract Infections in Children